Skip to main content
    B

    Bioceres Crop Solutions Corp (BIOX)

    Official site

    BASIC MATERIALS • AGRICULTURAL INPUTS • NASDAQ

    $0.19
    -0.01 (-4.81%)

    Market Cap: $12.74M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Bioceres Crop Solutions Corp (BIOX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Bioceres Crop Solutions (BIOX) has a market cap of $12.74M and an enterprise value of $230.74M. Its net debt of $218.00M equals 1710.60% of its market cap. It kept -93.45% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 1710.60% above the market cap, as debt exceeds cash.

    Market Cap$12.74M
    Enterprise Value$230.74M
    Latest price (Nov 17, 2026)$0.19

    Key Dates

    Last Earnings DateNov 11, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count held steady in the quarter ended Jun 30, 2026 and shrank 0.16% a year over 2 years.

    Shares Outstanding63.60M
    Shares Change (YoY)+0.63%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)-0.16%

    Valuation Ratios

    P/B Ratio0.3x
    P/FCF Ratio0.2x

    Enterprise Valuation

    Counting debt and cash, the company is valued at 86.6x EBITDA and 3.2x free cash flow.

    EV / Sales0.9x
    EV / EBITDA86.6x
    EV / FCF3.2x

    Price Statistics

    The stock is down 88.68% over 52 weeks and trades 36.67% below its 50-day average.

    Beta (1Y)2.18
    52-Week Change-88.68%
    1-Month Change-25.48%
    3-Month Change-54.16%
    6-Month Change-54.75%
    5-Year Change-98.39%
    Total Return (1Y)-88.68%
    Total Return (3Y CAGR)-74.69%
    Total Return (5Y CAGR)-58.72%
    Max Drawdown (1Y)-88.95%
    Max Drawdown (3Y)-98.63%
    Sharpe Ratio (1Y)-2.13
    Correlation with SPY (1Y)0.30
    50-Day Average$0.30
    200-Day Average$0.41
    52-Week Range$0.19 to $1.73
    RSI (14 Days)35.5
    Average Volume (20 Days)223.03K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.81x current liabilities, and total debt is 5.86x shareholder equity.

    Current Ratio0.81x
    Quick Ratio0.63x
    Debt / Equity5.86x
    Debt / EBITDA86.26x
    Interest Coverage0.06x

    Returns and Efficiency

    Return on invested capital is -15.36% and return on equity is -588.66% over the last 12 months.

    Return on Equity (ROE)-588.66%
    Return on Assets (ROA)-48.84%
    Return on Invested Capital (ROIC)-15.36%
    Return on Capital Employed (ROCE)-20.18%
    Asset Turnover0.40x
    Inventory Turnover3.20x
    Receivables Turnover1.88x
    Cash Conversion Cycle151 days

    Scores

    BIOX has an Altman Z-Score of -0.84, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-0.84
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $246.31M over the last 12 months is down 24.33% from the 12 months before.

    Revenue$246.31M
    Revenue Growth (YoY)-24.33%
    Gross Profit$87.26M
    Operating Income-$1.01M
    Pretax Income-$54.23M
    Net Income-$230.17M
    EBITDA$2.66M
    EBIT-$41.22M
    Reported EPS (TTM)-$0.88

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 8.30% of the $471.30M in total assets.

    Cash and Equivalents$11.20M
    Total Debt$229.20M
    Net Debt$218.00M
    Net Debt Per Share$3.43
    Working Capital-$51.80M
    Shareholder Equity$39.10M
    Book Value Per Share$0.61
    Tangible Book Value-$79.20M
    Total Assets$471.30M
    Total Liabilities$407.20M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    Capital Expenditures$1.59M
    FCF Per Share$1.13

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -0.41%, against a 5-year average of 6.78%.

    Gross Margin35.43%
    Operating Margin-0.41%
    Pretax Margin-22.02%
    Net Margin-93.45%
    EBITDA Margin1.08%
    EBIT Margin-16.73%
    Gross Margin (5Y Average)38.52%
    Operating Margin (5Y Average)6.78%
    Net Margin (5Y Average)-22.10%

    Growth

    Revenue fell 17.24% a year over 3 years.

    Revenue Growth (3Y CAGR)-17.24%
    Revenue Growth (5Y CAGR)+2.84%
    Operating Income Growth (3Y CAGR)-87.64%
    Book Value Per Share Growth (2Y CAGR)-64.73%

    Revenue and profit by year

    Dividends and Yields

    BIOX does not pay a dividend. Its free cash flow yield is 597.12%.

    FCF Yield597.12%
    Shareholder Yield0.00%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About BIOX

    What is BIOX's market cap?

    Bioceres Crop Solutions has a market cap of $12.74M. Its enterprise value, which adds debt and subtracts cash, is $230.74M.

    How many shares of BIOX are outstanding?

    Bioceres Crop Solutions has 63.60M shares outstanding. The count is up 0.63% from a year earlier.

    Does BIOX pay a dividend?

    No. Bioceres Crop Solutions does not pay a dividend.

    How much debt does BIOX have?

    Bioceres Crop Solutions has $229.20M of total debt and $11.20M of cash and equivalents, a net debt position of $218.00M.